A comprehensive view of Endo International PLC. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Endo sues Zydus over its alleged use of Endo's patented method to manufacture a Chantix generic that is free of impurities; Pfizer recalled Chantix in 2021 due to impurity issues
Published:
August 11, 2023
by FiercePharma
|
Endo International's Par Sterile Products starts shipping injectable Posaconazole in the US, the first generic of Merck's Noxafil, following FDA approval; injection used to prevent aspergillus and candida infections in severely immunocompromised patients
Published:
June 30, 2023
by Canada Newswire
|
Ask us about our Health Care Sector market view